Advertisement

Frühgeburt: pränatale und intrapartale Aspekte

  • L Spätling
  • H. Schneider

Zusammenfassung

Die Inzidenz der Frühgeburtlichkeit ist in den meisten Ländern konstant geblieben, und der eindrückliche Rückgang der Perinatalsterblichkeit ist Folge der verbesserten Überlebenschancen von Frühgeborenen, insbesondere der kleinen Frühgeborenen mit einem Geburtsgewicht von <1500 g.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. ACOG (1995) Preterm labor. Technical Bulletin 206: 1–10Google Scholar
  2. ACOG (1996) ACOG Committee opinion: Home uterine activity monitoring. No 172, Mai 1996. Committee on obstetric practice. Int J Gynaecol Obstet 54: 71CrossRefGoogle Scholar
  3. ACOG (2001) Assessment of risk factors of preterm birth — practice bulletin, No. 31. Obstet Gynecol 98: 709–716Google Scholar
  4. Altabef KM, Spencer IT, Zinberg S (1992) Intravenous nitroglycerine tot uterine relaxation of an inverted uterus. Am 1 Obstet Gynecol 166: 1237–1238Google Scholar
  5. Alvan G, Orme M, Bertilsson et al. (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18: 369–73Google Scholar
  6. Ancel PY, Bréart G (2000) Epidemiologie und Risikofaktoren der Frühgeburtlichkeit. Gynäkologe 33: 356–360CrossRefGoogle Scholar
  7. Andersen HE, Nugent CE, Wanty SD, Havashi RH (1990) Reduction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 163: 959–967Google Scholar
  8. Arabin, B, Hübener M, van Eyk J (2001) Zervixinsuffizienz — diagnostische, präventive und therapeutische Aspekte, Gynäkologe 34: 715–725CrossRefGoogle Scholar
  9. Arias F, Rodriquez L, Ravne SC, Kraus FT (1993) Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterrn labor and preterm ruptured membranes. Am J Obstet Gynecol 168: 585–591PubMedGoogle Scholar
  10. Badeyan G, Weislo M, Bussière E et al. (2000) La situation périnatale en France en 1998. Etudes et Résultats 73: 1–8Google Scholar
  11. Barth WH, Yeomas ER, Hankins GDV (1990) Emergent cerclage. Surg Gynecol Obstet 170: 323–326PubMedGoogle Scholar
  12. Bennetar C, Taieb J, Fernandez H, Lindenbaum A, Frydman R, Ville Y (1997) Rapid fetal fibronectin swab-test in preterm labor in patients treated by betamimetics. Eur J Obstet Gynecol Reprod Biol 72; 131–135CrossRefGoogle Scholar
  13. Berger TM, Büttiker V, Fauchère J-C et al. (2002) Empfehlungen zur Betreuung von Frühgeborenen an der Grenze der Lebensfähigkeit (Gestationsalter 22-26 SSW). Schweizer Ärztezeitung 93: 1589–1595Google Scholar
  14. Brocklehurst P, Hannah M, McDonald H (2001) Interventions for treating bacterial vaginosis in pregnancy (Cochrane Review) In: The Cochrane Library, Issue 2. Update Software, OxfordGoogle Scholar
  15. Buekens P, Alexander S, Boutsen M, Blondel B, Kaminski M, Reid M (1994) Randomized controlled trial of routine cervical examinations in pregnancy. Lancet 344: 841–844PubMedCrossRefGoogle Scholar
  16. Bukowski R, Saade GR (2001) new developments in the management of preterm labor. Semin Perinatol 25: 272–294PubMedCrossRefGoogle Scholar
  17. Bukowski R, MacKay L, Fittkow C et al. (2001) Inhibition of cervical ripening by local application of cyclooxygenase 2-inhibitor. Am J Obstet Gynecol 184: 1374PubMedCrossRefGoogle Scholar
  18. Burger M, Weber-Rässler T, Willmann M (1997) Measurement of the pregnant cervix by transvaginal sonography: an interobserver study and new standards to improve the interobserver variability. Ultrasound Obstet Gynecol 9: 188–193PubMedCrossRefGoogle Scholar
  19. Carey JC, Klebanoff MA, Hauth JC et al. (2000) Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 342: 534–540PubMedCrossRefGoogle Scholar
  20. Carlan SJ, O’Brien WF, O’Leary TD, Mastrogiannis D (1992) Randomized comparative trail of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 79: 223–228PubMedGoogle Scholar
  21. Challis JRG (2000) Mechanism of parturition and preterm labor. Obstet Gynecol Surv 55: 650–660PubMedCrossRefGoogle Scholar
  22. Chalmers I, Enkin M, Keirse MJNC (1989) Effective care in pregnancy and childbirth. Oxford University PressGoogle Scholar
  23. Challis JRG, Matthews SG, Gibb W, Lye S (2000) Endocrine and paracrine regulation of birth at term and preterm. Endocrine Res 21: 514–550CrossRefGoogle Scholar
  24. Chau CG, Gabert HA, Miller JM (1992) A prospective comparison of terbutaline and magnesium for tocolysis. Obstet Gynecol 80: 847–851PubMedGoogle Scholar
  25. Chazotte C, Cohen WR (1990) Catastrophic complications of previous cesarean section. Am J Obstet Gynecol 163: 738–742PubMedGoogle Scholar
  26. Collaborative Home Uterine Monitoring Study Group (1995) A multicentre randomized controlled trial of home uterine activity monitoring: active versus sham device. Am J Obstet Gynecol 173: 1120CrossRefGoogle Scholar
  27. Cram LF, Zapata MJ, Toy EC, Baker B (2002) Genitourinary infections and their association with preterm labor. Am Fam Physician 65: 241–248PubMedGoogle Scholar
  28. Dayson DC, Dannbe KH, Bamber JA et al. (1998) Monitoring women at risk for preterm labour. N Engl J Med 338: 15CrossRefGoogle Scholar
  29. El-Sayed YY, Riley ET, Holbrook RH Jr, Cohen SE, Chitkara U, Druzin ML (1999) Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor. Obstet Gynecol 93: 79–83PubMedCrossRefGoogle Scholar
  30. Fausett MB, Esplin MS, Yoder B et al. (2000) Indomethacin therapy for preterm labor prolongs gestation and is not associated with increased neonatal complications in infants delivered prior to 32 weeks. Am J Obstet Gynecol 182: 48Google Scholar
  31. Fawer CL, Calame A (1991) Significance of ultrasound appearances in the neurological development and cognitive abilities of preterm infants of 5 years. Eur J Pediatr 150: 515–520PubMedCrossRefGoogle Scholar
  32. Ferguson JE, Dyson DC, Holbrook RH et al. (1989a) Cardiovascular and metabolic effects associated with Nifedipine and Ritrodrine tocolysis. Am J Obstet Gynecol 161: 788–795PubMedGoogle Scholar
  33. Ferguson JE, Schutz T, Pershe R et al. (1989b) Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol 161: 1485–1490PubMedGoogle Scholar
  34. Forde R (1993) Clinical assessment of pregnant women’s psychological conditions, prematurity and birth weight. Scand J Prim Health Care 11: 130–134PubMedCrossRefGoogle Scholar
  35. Fuchs AR, Fuchs F, Husslein P et al. (1984) Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 150: 734–741PubMedGoogle Scholar
  36. Garcia-Velasco JA, Gonzales GA (1998) A prospective randomized trial of Nifedipine vs. Ritodrine in threatened preterm labor. Int J Gynecol Obstet 61: 239–444CrossRefGoogle Scholar
  37. Gazaway P, Mullins CL (1986) Prevention of preterm labor and premature rupture of membranes. Clin Obstet Gynecol 29: 835–840PubMedCrossRefGoogle Scholar
  38. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweel RL (1992) A review of premature birth and subclinical infection. Am J Obstet Gynecol 166: 1515–1528PubMedGoogle Scholar
  39. Goncalves LF, Chaiworapongsa T, Romero R (2002) Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 8: 3–13PubMedCrossRefGoogle Scholar
  40. Goodlin RC (1987) Surgical treatment of patients with hourglass shaped or ruptured membranes before the 25th week of gestation. Surg Gynecol Obstet 165: 410–412PubMedGoogle Scholar
  41. Grangers, Hollingsworth M, Weston A (1985) A comparison of several calciumantagonists on uterine vascular and cardiac muscles from the rat. Br J Pharmacol 85: 255CrossRefGoogle Scholar
  42. Grant A, Cochrane Database Systemic Review (2001) Elective or selective caesarean of the small baby?. A systemic review of the controlled trialsGoogle Scholar
  43. Groome LJ, Goldenberg RL, Cliver SP, Davis RO, Copper RL (1992) Neonatal periventricular-intraventricular hemorrhage after maternal beta-symphathomimetic tocolysis. The March of Dimes Multicenter Study Group. Am J Obstet Gynecol 167: 873–879PubMedGoogle Scholar
  44. Gyetvai K, Hannah ME, Hondett ED, Ohlsson A (1999) Tocolytics for preterm labor: a systematic review. Obstet Gynecol 94: 869–877PubMedCrossRefGoogle Scholar
  45. Hack M, Tavior HE, Klein N, Eiben R, Schattschneider C, Mercury-Minich N (1994) Schoolage outcome in children with birth weight under 750 g. N Engl J Med 331: 753PubMedCrossRefGoogle Scholar
  46. Hack M, Wright LL, Shankaran S et al. (1995) Very low birthweight outcomes of The National Institute of child Health and Human Development Neonatal Network, November 1989 to October 1990. Am J Obstet Gynecol 172: 457PubMedCrossRefGoogle Scholar
  47. Heine RP, McGregor JA, Dullien VK (1999) Accuracy of salivary estriol testing compared to traditional risk factor assessment in predicting preterm birth. Am J Obstet Gynecol 180: 215–218CrossRefGoogle Scholar
  48. Helleberg L (1981) Clinical pharmacokinetics of indomethacin. Clin Pharmacokinet. 6: 245–58.PubMedCrossRefGoogle Scholar
  49. Hentschel J, Arlettaz R, Bührer C (2001) Überlebenschancen und Langzeitprognose bei Geburt in der Grauzone der Lebensfähigkeit. Gynäkologe 34: 697–707CrossRefGoogle Scholar
  50. Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA (1989) The association between decreased amniotic fluid volume and treatment with non-steroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 160: 1525–1531PubMedGoogle Scholar
  51. Higgsby K, Xenakis EM, Taverstein CJ (1993) Do tocolytic agents stop preterm labour?. A critical and comprehensive review of safety and efficacy. Am J Obstet Gynecol 168: 1247Google Scholar
  52. Hirsch HA (1990) Technique of cesarean section for infants below 1500 g. In: Duc G, Huch A, Huch R (eds) The very low birth infant. Thieme, Stuttgart, pp 230–241Google Scholar
  53. Hoyme UB, Grosch A, Roemer VM, Saling E (2000) Die bakterielle Vaginose als Risikofaktor. Gynäkologe 33: 331–335CrossRefGoogle Scholar
  54. Huhta JC, Moise KJ, Fisher DJ et al (1987) Detection and quantiation of contraction of the fetal ductus arteriosus by doppler echocardiography. Circulation 75: 406–412PubMedCrossRefGoogle Scholar
  55. lams JD, Johnson FF, Hamer C (1990) Uterine activity and symptoms as predictors of preterm labour. Obstet Gynecol 76: 42 lams JD, Johnson FF, Parker M (1994) A prospective evaluation of the signs and symptoms of preterm labour. Obstet Gynecol 84: 227Google Scholar
  56. lams JD, Goldenberg RL, Mercer BM, Moawad AH et al. (2001) Term prediction study: can low-risk women destined for spontaneous preterm birth be identified?. Am J Obstet Gyneco 184: 652–655CrossRefGoogle Scholar
  57. Keirse MJNC (1990) Progesteron administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 97: 149–154PubMedCrossRefGoogle Scholar
  58. Keirse MJNC, Kanhai HHH (1981) An obstetrical viewpoint on preterm birth with particular reference to perinatal morbidity and mortality. In: Huisjes HJ (ed) Aspects of perinatal morbidity. Univ Boekhandel, Groningen, pp 1–35Google Scholar
  59. Kenyon SL, Taylor DJ, Tarnow-Mordi W, for the ORACLE Collaborative Study Group (2001) Broad-spectrum antibiotics for preterm labour: the ORACLE II randomised trial. Lancet 357: 989–994PubMedCrossRefGoogle Scholar
  60. King JE, Grant A, Kense MJNC (1988) Beta-mimetics in preterm labour: an overview of the randomized control trials. Br J Obstet Gynecol 95: 211–222CrossRefGoogle Scholar
  61. Kitchen WH, Permezell MJ, Doyle LW, Ford GW, Rickards HL, Kelley EA (1992) Changing obstetric practice and 2-year outcome of the fetus of birth under 1000 g. Obstet Gvnecol 79: 268–275Google Scholar
  62. Kuban KCK, Leviton A, Pagano M, Fento T, Strassfeld R, Wolff M (1992) Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhae in premature babies. J Clin Neurol 7: 70–76Google Scholar
  63. Lees CC, Locjacono A, Thompson C, Danti L, Black RS, Tanzi P, White IR, Campbell S (1999) Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group. Obstet Gynecol 94: 403–408PubMedCrossRefGoogle Scholar
  64. Lengyel E, Pildner von Steinburg S (2001) Die Physiologie der Zervixreifung. Der Gynäkologe 34: 708–714CrossRefGoogle Scholar
  65. Lettieri L, Vintzileos AM, Rodis IF, Albini SM, Salafia CM (1993) Does idiopathic preterm labor resulting in preterm labor birth exist?. Am J Obstet Gynecol 168: 1480–1485PubMedGoogle Scholar
  66. Levilon A, Pagano M, Kuban KCK (1988) Etiologic heterogeneity of intracranial hemorrhages in preterm newborns. Paediatr Neurol 4: 274–278CrossRefGoogle Scholar
  67. Locksmith G, Duffy P (2001) Infection, antibiotics and preterm delivery. Semin Perinatol 25: 295–309PubMedCrossRefGoogle Scholar
  68. Lockwood CJ (1999) Stress-associated preterm delivery: the role of corticotropin-releasing hormone. Am J Obstet Gynecol 180: 264–266CrossRefGoogle Scholar
  69. Lockwood CJ, Senyei AE, Dische R et al. (1991) Fetal febronectin and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325: 669–674PubMedCrossRefGoogle Scholar
  70. Lou HC, Nordentoft M, Jensen F, Pryds O, Nim J, Hemmingsen R (1992) Psychosocial stress and severe prematurity. Lancet 340: 54PubMedCrossRefGoogle Scholar
  71. Luke B (1993) Nutrition an prematurity. In: Witter FR, Keith LG (eds) Textbook of prematurity. Little & Brown, Boston, pp 25–39Google Scholar
  72. MacKey MC, Williams CA, Tiller CM (2000) Stress, preterm Labour and birth outcomes. J Adv Nurs 32: 666–674PubMedCrossRefGoogle Scholar
  73. Macones GA, Marder SJ, Clothier B, Stamilio DM (2001) The controversy surrounding indomethacin tocolysis Am J Obstet Gynecol 184: 264–272PubMedCrossRefGoogle Scholar
  74. Mari G, Kirshon B, Moise KJ, Lee W, Cotten DB (1989) Doppler assessment of the fetal and uteroplacental circulation during Nifedipine therapy for preterm labor. Am J Obstet Gynecol 161: 1514–1518PubMedGoogle Scholar
  75. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, Tomich PG (2002) Association between the use of antenatal magnesium sulfat in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 186: 1111–1118PubMedCrossRefGoogle Scholar
  76. Moise KJ (1993) The effect of advancing gestational age on the frequency of fetal ductal constriction secundary to maternal indomethacin use, Am J Obstet Gynecol 168: 1350–1353PubMedGoogle Scholar
  77. Moise KJ, Huta JC, Sharif DS et al. (1988) Indomethacin in the treatment of premature labor: Effects on the fetal ductus arteriosus. N Engl J Med 319: 327–331PubMedCrossRefGoogle Scholar
  78. Morales WJ, Madhav HM (1993) Efficacy and safety of indomethacin compared with magnesiumsulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 169: 97–102PubMedGoogle Scholar
  79. Morales WJ, Smith SG, Angel JL et al (1989) Efficacy and safety of Indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 74: 567–572PubMedGoogle Scholar
  80. Moutkin JM, Sherman D, Cohen H et al. (2000) Double-blind randomized, controlled trial of Atosiban and Ritodrine in treatment of preterm labour: a multicenter effectiveness and safety study. Am J Obstet Gynecol 182: 1191–1199CrossRefGoogle Scholar
  81. Palmer L, Blair E, Petterson B, Burton P (1995) Antenatal antecedents of moderate and severe cerebral palsy. Paediatr Perinat Epidemiol 9: 171–184PubMedCrossRefGoogle Scholar
  82. Papatsonis DN, Kok JH, van Geijn HP, Bleker OP, Ader HJ, Dekker GA (2000) Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 95: 477–481PubMedCrossRefGoogle Scholar
  83. Papiernik E (1984) Proposals for a programmed prevention policy of preterm birth. Clin Obstet Gynecol 27: 614–635PubMedCrossRefGoogle Scholar
  84. Papiernik E (1993) Prevention of preterm labour and delivery. Baillieres Clin Obstet Gynecol 7: 499–521CrossRefGoogle Scholar
  85. Perlman JM, Rollins N, Burns D, Risser R (1993) Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage and the very low birth weight neonate. Pediatrics 91: 474–480PubMedGoogle Scholar
  86. Piper PJ (1984) Formation and actions of leukotrienes. Physiol Rev 64: 744–761PubMedGoogle Scholar
  87. Quatero HWP, Fry C (1989) Placental corticotropin-releasing factor may modulate parturition. Placenta 10: 439–443CrossRefGoogle Scholar
  88. Raio L (2002) Screening-Untersuchungen auf eine drohende Frühgeburt. Gynäkologe 35: 661–664Google Scholar
  89. Raio L, Ghezzi F, DiNaro E, Gomez R, Lüscher KP (1997) Duration of pregnancy after carbon dioxid laser conisation of the cervix: influence of cone height. Obstet Gynecol 90: 978–982PubMedCrossRefGoogle Scholar
  90. Ratzel R (1995) Der Entbindungsmodus beim kleinen Frühgeborenen — gibt es juristische Vorgaben?. ZGeburtsh Neonatol 199: 203Google Scholar
  91. Repke JT, Niebyl Z (1985), Role of prostaglandin synthetase inhibitors in the treatment of preterm labor. Semin Reprod Endocr 3: 259CrossRefGoogle Scholar
  92. Reuss ML, Gordon HR (1995) Obstetrical judgements of viability, and perinatal survival of extremely low-birth-weight infants. Am J Publ Health 85: 362CrossRefGoogle Scholar
  93. Revak A, Hannh ME, Sue-A-Quan AK (1998) Fetal fibronectin asa predictor of preterm birth: an overview. Am J Perinatol 15: 613–621CrossRefGoogle Scholar
  94. Roberts WE, Perry KG, Neff III RW, Washburne JF, Morrison JC (1995) The irritable uterus: a risk factor for preterm birth. Am J Obstet Gynecol 172: 138–142PubMedCrossRefGoogle Scholar
  95. Rodts-Palenik S, Morrison JC (2000) Tocolysis: an update for the practitioner. Obstet Gynecol. Surv 57: 9–34Google Scholar
  96. Romero R, Emamian M, Wan M, Grzybowski C, Hobbins IC, Mitchell MD (1987) Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition. Obstet Gynecol 70: 849–851PubMedGoogle Scholar
  97. Romero R, Sepulveda W, Mazor M, Brandt F, Cotton DB, Dinarello CA, Mitchell MD (1992) The natural interleukin-1-receptor antagonist in term and preterm parturitation. Am J Obstet Gynecol 167: 863–872PubMedGoogle Scholar
  98. Saling E (1981) Der frühe totale Muttermundverschluss zur Vermeidung habitueller Aborte und Frühgeburten. Z Geburtsh Perinatol 185: 259–261Google Scholar
  99. Saling E, Schumacher E (1996) Der operative Totale Muttermund-Verschluss (TMV) — Erhebungen von Daten einiger Kliniken, die den TMV einsetzen. Z Geburtsh Neonatol 200: 82–87Google Scholar
  100. Saling E, Schumacher E (1997) Ergebnisse einer Nachuntersuchung von Müttern nach vorausgegangenen operativen »Totalen Muttermund-Verschlüssen« (TMV) unter Berücksichtigung auch der Daten ihrer Kinder. Z Geburth Neonatol 201: 122–127Google Scholar
  101. Saling E, Raitsch S, Placht A, Fuhr N, Schumacher E (1994) Frühgeburtenvermeidungsprogramm und Selbstvorsorge-Aktion für Schwangere. Frauenarzt 35: 84–92Google Scholar
  102. Schaefer WR, Zarahdink HP (2001) Programmierte Eskalation — Steuerung der Geburt. Geburtsh Frauenheilkd 61: 157–166CrossRefGoogle Scholar
  103. Scheerer LJ, Lam F, Bartolucci L et al. (1989) A new technique for reduction of prolabs fetal membrane for emergency cervical cerclage. Obstet Gynecol 74: 408–410PubMedGoogle Scholar
  104. Schneider H (2000) Prospektive Geburtsleitung bei kleinen Frühgeborenen. In: Friese K, Plath C, Friese V (Hrsg) Frühgeburt und Frühgeborenes. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  105. Schneider H, König C (1990) Vorsorgeuntersuchung bei Risikoschwangerschaften. Schweiz Med Wochenschr 120: 247–254PubMedGoogle Scholar
  106. Schneider H, Naiem A, Maick, A, Hängg W (1994) Ätiologische Klassifikation der Frühgeburt und ihre Bedeutung für die Prävention. Geburtsh Frauenheilkd 54: 12–19CrossRefGoogle Scholar
  107. Spätling L, Spätling C (1988) Magnesium supplementation during pregnancy. A double blind study. Br J Obstet Gynaecol 95: 120–125PubMedCrossRefGoogle Scholar
  108. Spätling L, Kunz PA, Huch R, Huch A (1984) Magnesium and calcium excretion during pregnancy. Mag Bull 6: 91–93Google Scholar
  109. Spätling L, Fallenstein F, Schneider H, Dancis J (1989) Bolus tocolysis: treatment of preterm labor with pulsatile administration of beta-adrenergic agonists. Am J Obstet Gynecol 160: 713–717PubMedGoogle Scholar
  110. Spätling L, Behrens C, Hasenburg A, Fallenstein F (1997) External four channel tocography in preterm Labor: First results. J Perinat Med 25: 43–48PubMedCrossRefGoogle Scholar
  111. Strebel R, Bucher HU (1994) Bessere Überlebenschance für extrem kleine Frühgeburten in der Schweiz. Schweiz Med Wochenschr 124: 1653–1659PubMedGoogle Scholar
  112. To MS, Palaniappan V, Skentou C, Gibb D, Nicolaides K (2002) Elective cerclage vs. ultrasound-indicated cerclage in high-risk pregnancies. Ultrasound Obstet Gynecol 19: 475–477PubMedCrossRefGoogle Scholar
  113. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carvonne B (2001) Tokolysis with nifedipine or betaadrenergic agonists: a metaanalysis. Obstet Gynecol 97: 840–847PubMedCrossRefGoogle Scholar
  114. Ugwumadu AH (2002) Bacterial vaginosis in pregnancy. Curr Opin Obstet Gynecol 14: 115–118PubMedCrossRefGoogle Scholar
  115. Vetter K (2001) Zervixinsuffizienz: operative Möglichkeiten. Gynäkologe 34: 726–731CrossRefGoogle Scholar
  116. Veyver JB, van den Moise KJ (1993) Prostaglandinsynthetase inhibitors in pregnancy. Obstet Gynec Surv 48: 493–502CrossRefGoogle Scholar
  117. Welsch A, Nicolaides K (2002) Cervical screening for preterm delivery. Curr Opin Obstet Gynecol 14: 196–202Google Scholar
  118. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR (2000) Neurologic and developmental disability after extremely preterm birth. N Engl J Med 343: 378–384PubMedCrossRefGoogle Scholar
  119. Zahn V (1978) Physiologie der Uleruskontraktionen. Z Geburtsh Perinatol 182: 263–268Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • L Spätling
  • H. Schneider

There are no affiliations available

Personalised recommendations